SI-BONE (NASDAQ:SIBN) Announces Quarterly Earnings Results

SI-BONE (NASDAQ:SIBN) released its quarterly earnings results on Monday. The company reported ($0.22) EPS for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.04, Yahoo Finance reports. The company had revenue of $39.97 million during the quarter, compared to analysts’ expectations of $38.95 million. SI-BONE had a negative return on equity of 25.14% and a negative net margin of 29.93%. During the same period last year, the business posted ($0.30) earnings per share.

SI-BONE Stock Up 1.3 %

Shares of NASDAQ SIBN opened at $14.22 on Wednesday. The firm has a market cap of $586.01 million, a price-to-earnings ratio of -13.05 and a beta of 1.20. The company’s 50-day simple moving average is $14.05 and its 200-day simple moving average is $15.92. The company has a quick ratio of 8.75, a current ratio of 9.76 and a debt-to-equity ratio of 0.22. SI-BONE has a 52-week low of $11.76 and a 52-week high of $24.33.

Wall Street Analyst Weigh In

SIBN has been the subject of several research analyst reports. Morgan Stanley reduced their price objective on SI-BONE from $21.00 to $19.00 and set an “overweight” rating for the company in a research note on Tuesday. Truist Financial decreased their target price on shares of SI-BONE from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Tuesday. JMP Securities reissued a “market outperform” rating and issued a $32.00 price objective on shares of SI-BONE in a report on Tuesday, May 7th. Finally, Needham & Company LLC decreased their target price on shares of SI-BONE from $27.00 to $19.00 and set a “buy” rating for the company in a research note on Tuesday. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat, SI-BONE has an average rating of “Buy” and a consensus price target of $23.00.

Insider Activity at SI-BONE

In other SI-BONE news, CFO Anshul Maheshwari sold 2,441 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $15.14, for a total transaction of $36,956.74. Following the completion of the sale, the chief financial officer now directly owns 204,241 shares in the company, valued at approximately $3,092,208.74. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, insider Anthony J. Recupero sold 3,309 shares of the firm’s stock in a transaction dated Tuesday, July 2nd. The shares were sold at an average price of $12.92, for a total value of $42,752.28. Following the transaction, the insider now directly owns 243,629 shares of the company’s stock, valued at $3,147,686.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Anshul Maheshwari sold 2,441 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $15.14, for a total value of $36,956.74. Following the transaction, the chief financial officer now owns 204,241 shares in the company, valued at $3,092,208.74. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,956 shares of company stock valued at $172,480. 5.40% of the stock is owned by corporate insiders.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.